Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00723359 · COMPLETED
Trial details
- NCT number
- NCT00723359
- Sponsor
- Biotest Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2012-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.